Physician profile
Brent Hoffman
NPI 1609339019
$1,562.76
in general payments reported to CMS, 2019-2025
9 companies · $473 in 2025
The $473 reported for 2025 was less than what a typical Cornea and External Diseases Specialist provider received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $166 · 2023: $433 · 2024: $240 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $763.16 | 2021-2025 | Clareon Panoptix Pro, Acrysof Iq Panoptix Uv Iol, Rocklatan |
| Glaukos Corporation | $467.63 | 2023-2025 | Ce-Marked Kxla System, Kxl1b-Ce-Marked Kxlsystem, Kxl System (Not Refurbished) |
| Aerie Pharmaceuticals, INC. | $122.09 | 2021 | |
| Bausch & Lomb Americas INC. | $86.95 | 2024-2025 | Vyzulta, Envista Envy Iol, Xiidra |
| Harrow Eye, LLC | $39.34 | 2025 | Vevye |
| Johnson & Johnson Surgical Vision, INC. | $29.60 | 2023 | Tecnis Simplicity, Tecnis Iol, Veritas Vision System |
| Oyster Point Pharma, INC. | $20.67 | 2025 | Tyrvaya, Ryzumvi |
| Sight Sciences, INC. | $17.24 | 2023 | Omni Surgical System |
| Glaxosmithkline, LLC. | $16.08 | 2025 | Blenrep |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.